A global pharma unified fragmented medical and commercial intelligence on Within3 for a launch in an unfamiliar therapeutic area.
Insight gathering was consultant-heavy and split across departments and multiple technology versions. Within3's platform consolidated the data and used domain-intelligent AI engines with compliant outputs. The page reports real-time medical-commercial collaboration and a longitudinal market view, without quantified figures.
Within3 is a medical affairs insights platform, used by pharma for virtual advisory boards and AI-supported insights reporting from field, trial and social data
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Within3 on its own site — read the original case study on within3.com ↗
Related use cases
- 01A top-5 pharma used Within3's AI-powered Launch Intelligence to find mental health professionals as an unplanned prescriber segment.
- 02A top pharma used Within3's Launch Intelligence to address diagnostic delays for a chronic gastrointestinal condition.
- 03A midsize pharma's medical affairs team replaced manual insight reporting with Within3's AI-supported Insights Reporting.
- 04A multinational pharma trained 700+ investigators and site staff for a Phase 3 breast cancer trial on Within3's learning hub.
- 05A medical affairs team ran two asynchronous virtual advisory boards across four European countries on Within3.
- 06A medical affairs team used a 17-day Within3 virtual advisory board to gather internal feedback on training.